Literature DB >> 19748521

The virulence variability of different Acinetobacter baumannii strains in experimental pneumonia.

Matthieu Eveillard1, Christophe Soltner, Marie Kempf, Jean-Paul Saint-André, Carole Lemarié, Catherine Randrianarivelo, Harald Seifert, Michel Wolff, Marie-Laure Joly-Guillou.   

Abstract

OBJECTIVES: Our objective was to compare the virulence of 5 strains of Acinetobacter baumannii by using a mouse model of pneumonia.
METHODS: Six-week old female C3H/HeN mice were used. The pneumonia was inducted by intra-tracheal inoculation of 5.10(6) bacteria. Spontaneous outcome was evaluated by mortality, mice weight variations, and a clinical score. Bacterial counts in lungs, spleen and blood, and inflammatory response in lungs (dosages of tumor necrosis factor-alpha and macrophage inflammatory protein-2) were also measured. Lastly, a histological examination of lungs was performed for 3 strains, giving a histological score.
RESULTS: Global mortality varied from 13% to 79% (P<10(-4)). Bacterial counts in lungs within the 4 days following inoculation varied significantly according to different strains. The evolution curves of bacterial counts were also different. There was a significant correlation between the clinical score and mortality (P<0.05) but not between bacterial counts in lungs and mortality. The increase of pro-inflammatory mediator production in lungs and the histological score also varied according to strains.
CONCLUSIONS: These results demonstrate the variability of the virulence between strains, and suggest that bacterial proliferation is not the only virulence factor responsible for the pathogenesis in A. baumannii pneumonia. Copyright 2009 The British Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19748521     DOI: 10.1016/j.jinf.2009.09.004

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  36 in total

1.  Insight into innovative approaches to battle Acinetobacter baumannii infection therapy struggles.

Authors:  Luis A Actis
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

2.  Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness.

Authors:  Rafael López-Rojas; Michael J McConnell; Manuel Enrique Jiménez-Mejías; Juan Domínguez-Herrera; Felipe Fernández-Cuenca; Jerónimo Pachón
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

3.  Clinical characteristics and outcomes of bacteremia due to different genomic species of Acinetobacter baumannii complex in patients with solid tumors.

Authors:  M-C Chiang; S-C Kuo; S-J Chen; S-P Yang; Y-T Lee; T-L Chen; C-P Fung
Journal:  Infection       Date:  2011-09-02       Impact factor: 3.553

4.  MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.

Authors:  MinJie Ju; BoFei Liu; HongYu He; ZhunYong Gu; YiMei Liu; Ying Su; DuMing Zhu; Jing Cang; Zhe Luo
Journal:  Cell Cycle       Date:  2018-09-19       Impact factor: 4.534

5.  GigC, a LysR Family Transcription Regulator, Is Required for Cysteine Metabolism and Virulence in Acinetobacter baumannii.

Authors:  Michael J Gebhardt; Daniel M Czyz; Shweta Singh; Daniel V Zurawski; Lev Becker; Howard A Shuman
Journal:  Infect Immun       Date:  2020-12-15       Impact factor: 3.441

Review 6.  Regulatory networks important for survival of Acinetobacter baumannii within the host.

Authors:  Jessie L Allen; Brooke R Tomlinson; Leila G Casella; Lindsey N Shaw
Journal:  Curr Opin Microbiol       Date:  2020-05-06       Impact factor: 7.934

7.  A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain.

Authors:  Greg Harris; Rhonda Kuo Lee; Christopher K Lam; Gregory Kanzaki; Girishchandra B Patel; H Howard Xu; Wangxue Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

8.  Severe Acinetobacter baumannii sepsis is associated with elevation of pentraxin 3.

Authors:  Patrick M Ketter; M Neal Guentzel; Beverly Schaffer; Maryanne Herzig; Xiaowu Wu; Robbie K Montgomery; Bijaya K Parida; Chriselda G Fedyk; Jieh-Juen Yu; James Jorgensen; James P Chambers; Andrew P Cap; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2014-07-07       Impact factor: 3.441

9.  Validation of a novel murine wound model of Acinetobacter baumannii infection.

Authors:  Mitchell G Thompson; Chad C Black; Rebecca L Pavlicek; Cary L Honnold; Matthew C Wise; Yonas A Alamneh; Jay K Moon; Jennifer L Kessler; Yuanzheng Si; Robert Williams; Suleyman Yildirim; Benjamin C Kirkup; Romanza K Green; Eric R Hall; Thomas J Palys; Daniel V Zurawski
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

10.  Azithromycin attenuates lung inflammation in a mouse model of ventilator-associated pneumonia by multidrug-resistant Acinetobacter baumannii.

Authors:  Koichi Yamada; Katsunori Yanagihara; Norihito Kaku; Yosuke Harada; Yohei Migiyama; Kentaro Nagaoka; Yoshitomo Morinaga; Shigeki Nakamura; Yoshifumi Imamura; Taiga Miyazaki; Koichi Izumikawa; Hiroshi Kakeya; Hiroo Hasegawa; Hiroshige Mikamo; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.